|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Antitumor Activity of a Combination
of Trastuzumab (Herceptin) and Oral Fluoropyrimidine S-1 on Human
Epidermal Growth Factor Receptor 2-Overexpressing Pancreatic
Cancer Oncol Rep. 2007 Aug;18(2):433-9.
PMID: 17611667 |
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |